ArticleFrontiers in oncology2024

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study.

Laura Patton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.